Illumina, Inc. (ILMN) CEO Francis deSouza on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Illumina stock tanks as gene-sequencing company misses expectations and issues bleak outlookMarket Watch • 08/11/22
Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Access to GenomicsPRNewsWire • 08/08/22
Is Most-Watched Stock Illumina, Inc. (ILMN) Worth Betting on Now?Zacks Investment Research • 08/05/22
Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab CapabilitiesPRNewsWire • 07/27/22
Grail and National Health Service (NHS) England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection TestBusiness Wire • 07/18/22
Illumina to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022PRNewsWire • 07/14/22
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero TargetPRNewsWire • 07/14/22